OKYO Pharma Limited (OKYO:NASDAQ) rocketted at $3.74, representing a gain of 58.5%. On Fri, Feb 17, 2023, OKYO:NASDAQ hit a New 2-Week High of $3.74. From Mon, Feb 06, 2023, the stock recorded 42.86% Up Days and 25.00% Green Days
The stock spiked on Fri, Feb 17, 2023 at $7 with a volume of 19M+.
About OKYO Pharma Limited (OKYO:NASDAQ)
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 97.28%
- OKYO Pharma Limited (OKYO:NASDAQ), 58.47%
- Movella Holdings Inc Com (MVLA:NASDAQ), 46.56%
- Apexigen Inc Com (APGN:NASDAQ), 44.21%
- AMC Networks Inc. (AMCX:NASDAQ), 32.34%
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 27.45%
- MacroGenics, Inc. (MGNX:NASDAQ), 25.67%
- United States Cellular Corporation (USM:NYSE), 24.52%
- Telephone and Data Systems, Inc. (TDS:NYSE), 23.09%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 22.46%